Xconomy Forum: What’s Hot in Boston Biotech

Life sciences innovation is moving fast these days, and perhaps nowhere is this more evident than in Boston. Local companies, researchers, and entrepreneurs are pursuing some of the boldest ideas in the field—T-cell therapy, gene therapy, and microbiome analysis, among others. What’s more, they’re seeing real results, in human trials, that indicate these approaches might soon change the way a number of diseases are treated. But a whole host of hurdles still have to be cleared. How can we avoid the pitfalls of the past, and turn these innovative visions into a reality? What’s it going to take to get new types of treatments approved? And how will we pay for them? Join Xconomy as we bring together a group of Boston biotech’s top innovators, entrepreneurs, investors, and leaders as we explore the brightest spots on the life sciences horizon.

Confirmed Speakers:

  • David Altshuler
    • Executive VP of Global Research and CSO, Vertex Pharmaceuticals
  • Susan Lindquist
    • Member, Whitehead Institute; Scientific Founder, Yumanity Therapeutics
  • Noubar Afeyan
    • Managing Partner and CEO, Flagship Ventures
  • Alexis Borisy
    • Chairman, Foundation Medicine; Partner, Third Rock Ventures
  • Tony Coles
    • CEO, Chairman, and Founding Investor, Yumanity Therapeutics
  • James Collins
    • Termeer Professor of Medical Engineering & Science, MIT
  • Olivier Danos
    • Senior Vice President, Gene Therapy, Biogen Idec
  • Michelle Dipp
    • Co-founder and CEO, OvaScience
  • Peter Kolchinsky
    • Managing Member and Portfolio Manager, RA Capital Management
  • Adam Koppel
    • Senior Vice President and Chief Strategy Officer, Biogen Idec
  • Marian Nakada
    • VP of Venture Investments, Johnson & Johnson Innovation
  • Amir Nashat
    • Managing Partner, Polaris Partners
  • Bernat Olle
    • Principal, PureTech Ventures
  • Steve Paul
    • President and CEO, Voyager Therapeutics
  • Samantha Singer
    • COO, The Broad Institute of MIT and Harvard
  • Chuck Wilson
    • CEO and President, Unum Therapeutics

Follow us on Twitter:

@Xconomy #xconbio


Registration & Networking: 12:30 – 1:30 pm
Program: 1:30 – 5:30 pm
Networking Reception: 5:30 – 6:30 pm
View our full agenda

Registration Information:

We are sold out! You can add your name to the waitlist here.

*Speakers and program schedule are subject to change.

Biogen Idec
Cote Orphan
Mintz Levin